Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 606 | 108 | 17.8 | 318 | 52.5 | 131 | 21.6 | 31 | 5.1 | 18 | 3.0 |
2015-2019 | 631 | 111 | 17.6 | 322 | 51.0 | 145 | 23.0 | 32 | 5.1 | 21 | 3.3 |
2014-2018 | 609 | 111 | 18.2 | 312 | 51.2 | 135 | 22.2 | 26 | 4.3 | 25 | 4.1 |
2013-2017 | 589 | 114 | 19.4 | 291 | 49.4 | 133 | 22.6 | 34 | 5.8 | 17 | 2.9 |
2012-2016 | 614 | 119 | 19.4 | 313 | 51.0 | 133 | 21.7 | 32 | 5.2 | 17 | 2.8 |
2011-2015 | 607 | 127 | 20.9 | 300 | 49.4 | 133 | 21.9 | 31 | 5.1 | 16 | 2.6 |
2010-2014 | 625 | 130 | 20.8 | 313 | 50.1 | 135 | 21.6 | 34 | 5.4 | 13 | 2.1 |
2009-2013 | 658 | 135 | 20.5 | 331 | 50.3 | 143 | 21.7 | 39 | 5.9 | 10 | 1.5 |
2008-2012 | 662 | 132 | 19.9 | 324 | 48.9 | 154 | 23.3 | 34 | 5.1 | 18 | 2.7 |
2007-2011 | 654 | 128 | 19.6 | 310 | 47.4 | 158 | 24.2 | 37 | 5.7 | 21 | 3.2 |
2006-2010 | 603 | 110 | 18.2 | 283 | 46.9 | 145 | 24.0 | 39 | 6.5 | 26 | 4.3 |
2005-2009 | 549 | 92 | 16.8 | 259 | 47.2 | 128 | 23.3 | 39 | 7.1 | 31 | 5.6 |
2004-2008 | 533 | 80 | 15.0 | 254 | 47.7 | 129 | 24.2 | 38 | 7.1 | 32 | 6.0 |
2003-2007 | 506 | 73 | 14.4 | 257 | 50.8 | 111 | 21.9 | 33 | 6.5 | 32 | 6.3 |
2002-2006 | 475 | 72 | 15.2 | 241 | 50.7 | 98 | 20.6 | 26 | 5.5 | 38 | 8.0 |
2001-2005 | 503 | 82 | 16.3 | 258 | 51.3 | 105 | 20.9 | 21 | 4.2 | 37 | 7.4 |
2000-2004 | 528 | 89 | 16.9 | 260 | 49.2 | 114 | 21.6 | 21 | 4.0 | 44 | 8.3 |
1999-2003 | 496 | 87 | 17.5 | 237 | 47.8 | 106 | 21.4 | 16 | 3.2 | 50 | 10.1 |
1998-2002 | 517 | 86 | 16.6 | 249 | 48.2 | 117 | 22.6 | 19 | 3.7 | 46 | 8.9 |
1997-2001 | 545 | 82 | 15.0 | 281 | 51.6 | 119 | 21.8 | 21 | 3.9 | 42 | 7.7 |
1996-2000 | 518 | 69 | 13.3 | 266 | 51.4 | 118 | 22.8 | 23 | 4.4 | 42 | 8.1 |
1995-1999 | 468 | 55 | 11.8 | 257 | 54.9 | 103 | 22.0 | 19 | 4.1 | 34 | 7.3 |
1994-1998 | 458 | 46 | 10.0 | 263 | 57.4 | 97 | 21.2 | 22 | 4.8 | 30 | 6.6 |
1993-1997 | 403 | 35 | 8.7 | 229 | 56.8 | 85 | 21.1 | 24 | 6.0 | 30 | 7.4 |
1992-1996 | 370 | 28 | 7.6 | 187 | 50.5 | 85 | 23.0 | 22 | 5.9 | 48 | 13.0 |
1991-1995 | 353 | 26 | 7.4 | 176 | 49.9 | 71 | 20.1 | 22 | 6.2 | 58 | 16.4 |
1990-1994 | 344 | 27 | 7.8 | 161 | 46.8 | 64 | 18.6 | 23 | 6.7 | 69 | 20.1 |
1989-1993 | 337 | 25 | 7.4 | 144 | 42.7 | 61 | 18.1 | 24 | 7.1 | 83 | 24.6 |
1988-1992 | 323 | 25 | 7.7 | 124 | 38.4 | 53 | 16.4 | 21 | 6.5 | 100 | 31.0 |
1987-1991 | 272 | 21 | 7.7 | 103 | 37.9 | 37 | 13.6 | 24 | 8.8 | 87 | 32.0 |
1986-1990 | 254 | 14 | 5.5 | 77 | 30.3 | 35 | 13.8 | 21 | 8.3 | 107 | 42.1 |
1985-1989 | 234 | 14 | 6.0 | 56 | 23.9 | 36 | 15.4 | 19 | 8.1 | 109 | 46.6 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |